News
What happens when you stop taking Ozempic®? There’s no one-size-fits-all answer to this question. When you stop taking ...
Thirty-nine percent of millennials and 35% of Gen Z say access to weight loss drugs would improve their job satisfaction or ...
18h
Woman's World on MSNIs Okra Nature's Ozempic? Learn the Truth About This Weight Loss Hack
If you've spent any time in the south, you're probably familiar with the distinctive crispy exterior and soft interior of ...
LipoVive offers a safer, research-backed alternative, supporting metabolic balance, curbing cravings, and promoting steady ...
More studies are needed, but patients should consider adding exercise and ensure adequate protein intake to maximize the ...
GLP-1 drugs for diabetes and weight loss are difficult for some people to inject weekly. A new slow-release gel, tested in rats, could help.
17hOpinion
MedPage Today on MSNLifestyle Interventions Should Not be Replaced by GLP-1s
The "try and fail" language is flawed when weight loss is used as the primary measure of success with lifestyle interventions ...
Gut health is finally becoming cool, which means more brands are touting the fiber available in their products.
20h
Woman's World on MSNShrink Thyroid Belly Fat With a Simple Diet That Revs Your Metabolism
Many of us know the bad relationship between low thyroid function and weight gain. It can be a reckless duo like Bonnie and ...
Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are ...
The researchers first tested their hypothesis by delivering ODN directly to the hindbrain of rats. Once treated, the rats ...
A new international study reveals that GLP-1 receptor agonists—commonly used for weight loss—may significantly reduce the risk of dementia in people with type 2 diabetes, outperforming metformin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results